UTMB Clinical and Translational Science Award
UTMB 临床和转化科学奖
基本信息
- 批准号:10611942
- 负责人:
- 金额:$ 277.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-08-18 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAddressAffectAfrican AmericanAgeCharacteristicsClinicClinical ResearchClinical SciencesClinical SkillsClinical TrialsClinical Trials NetworkClinical and Translational Science AwardsCollaborationsCommunicationCommunitiesCountryCourse ContentDataDiscipline of NursingDiverse WorkforceEducationEducational CurriculumEffectivenessEntrepreneurshipEthnic OriginGenderGeriatricsGoalsHandHealthHealth OccupationsHealth SciencesHealth systemHealthcare ActivityHeterogeneityHispanicHomeHospitalsIndividualInformaticsInstitutionInstitutional Review BoardsLeadershipLearningLongevityMedicalMethodologyMethodsMinorityMissionModelingMulti-Institutional Clinical TrialNational Center for Advancing Translational SciencesNative AmericansOutcomes ResearchParticipantPatient CarePatient-Focused OutcomesPediatricsPhasePopulationPregnancyRaceResearchResearch PersonnelResearch SupportResource SharingResourcesSchoolsScienceServicesSourceSpecial PopulationStructureTechnologyTestingTexasTrainingTranslation ProcessTranslational ResearchUniversitiesWorkanalytical toolcareercommunity engagementcomparative effectivenessdata resourcedata sharingdesigneffective interventionexperiencehealth goalsimprovedinformatics infrastructureinformatics traininginnovationinter-institutionalinteroperabilityknowledge basemedical schoolsmeetingsmulti-site trialmultidisciplinarynoveloperationpatient populationprogramsskillstranslational pipeline
项目摘要
Contact PD/PI: Urban, Randall J.
O. Overall
Project Summary
The University of Texas Medical Branch (UTMB) has participated as a CTSA hub since 2009. The academic home
of our CTSA, the Institute for Translational Sciences (ITS), has brought together multidisciplinary translational
teams (MTTs) and the resources necessary to accelerate discoveries toward better health for individuals and
communities. Building on our existing strengths, CTSA initiatives have transformed UTMB’s learning and research
culture to one that embraces multidisciplinary translational team (MTT) approaches to addressing significant
health problems. We have developed novel educational curricula, significant clinical research programs in
special populations with multisite clinical trials, and provided leadership in the Texas Regional CTSA consortium
(TRCC) and nationally. UTMB’s CTSA hub supports the health goals of the nation by generating, testing and
disseminating integrative team science, education and best practices through stakeholder involvement at all
stages. Managed by a continuous improvement model using an Innovation Scorecard, we will address six
specific aims, to: 1) Expand the knowledge base and practice of collaborative teams to advance the conduct
of translational research through team-based innovation. Building on our team science leadership, we will test,
learn, and disseminate multi-institutional teaming to enhance the quality, efficiency, effectiveness, and diversity
of clinical and translational research. 2) Engage local, regional, and national stakeholders to make research more
effective at meeting their needs. We will build upon our relationships to extend inter-institutional partnerships, and
to work with stakeholders to disseminate scientific findings and advance the field of community engagement. 3)
Harness the potential of harmonized large data platforms across the translational spectrum to improve research
efficiency, develop technologies to support research teams, and share resources with researchers across the
CTSA network. Our aims are designed to enhance our informatics infrastructure and training with regional and
CTSA network interoperability putting existing and novel analytics tools into the hands of users. 4) Promote
clinical and translational research across the lifespan including special populations. We will expand upon our
significant strengths in multi-site trials in special populations to proactively engage the NCATS Trial Innovation
Network for new trials originating from UTMB. 5) Improve training for a diverse workforce in the authentic skills
needed to advance all phases of clinical and translational research. Our integrated U, K, and T programs will
include participants with diverse professional and educational experience, as well as diverse age, gender, racial,
and ethnic characteristics. 6) Develop and disseminate improved methods and processes for translation from
discovery to improved health. We will apply a continuous improvement approach to understand barriers, develop
effective interventions, and disseminate improvements in translational science and operations.
Page 430
Project Summary/Abstract
Contact PD/PI: Urban, Randall J.
Narrative
UTMB’s CTSA Hub will work with local, regional, and national partners to support translational research and
accelerate discoveries toward better health. We will train a diverse workforce and build multidisciplinary teams
to conduct efficient, high-quality clinical research across the lifespan that includes understudied populations.
We will integrate our research and healthcare activities and will generate, apply and share data and best
practices across institutions.
Page 431
联系PD/PI:Urban,Randall J.
O.整体
项目摘要
德克萨斯大学医学分支(UTMB)自2009年以来一直作为CTSA中心参与。学术之家
我们的CTSA,翻译科学研究所(ITS),汇集了多学科的翻译
团队(MTT)和必要的资源,以加速发现更好的健康为个人,
社区.在我们现有优势的基础上,CTSA的举措改变了UTMB的学习和研究
文化的一个拥抱多学科翻译团队(MTT)的方法,以解决重大
健康问题我们开发了新颖的教育课程,重要的临床研究项目,
多中心临床试验的特殊人群,并在德克萨斯州地区CTSA联盟中发挥领导作用
(国家)和国家。UTMB的CTSA中心通过生成,测试和
通过利益相关者的参与传播综合团队科学、教育和最佳实践
阶段通过使用创新记分卡的持续改进模型进行管理,我们将解决六个问题
具体目标是:1)扩大协作团队的知识基础和实践,以推进行为
通过基于团队的创新进行转化研究。在我们团队科学领导力的基础上,我们将测试,
学习和传播多机构合作,以提高质量,效率,有效性和多样性
临床和转化研究。2)让地方、区域和国家利益相关者参与进来,
有效地满足他们的需求。我们将利用我们的关系,扩大机构间的伙伴关系,
与利益攸关方合作,传播科学成果,推动社区参与。第三条
充分利用跨翻译范围的协调大型数据平台的潜力,以改进研究
提高效率,开发技术以支持研究团队,并与研究人员共享资源。
CTSA网络。我们的目标是加强我们的信息学基础设施和培训,
CTSA网络互操作性将现有的和新的分析工具交到用户手中。4)促进
包括特殊人群在内的整个生命周期的临床和转化研究。我们将扩大我们的
在特殊人群中进行多中心试验的显著优势,以积极参与NCATS试验创新
来自UTMB的新试验网络。5)改善对多样化劳动力的真实技能培训
需要推进临床和转化研究的各个阶段。我们的综合U,K和T计划将
包括具有不同专业和教育经验以及不同年龄、性别、种族
和民族特征。6)制定和传播经改进的翻译方法和程序,
发现改善健康。我们将采用持续改进的方法来了解障碍,
有效的干预措施,并传播转化科学和操作的改进。
页面430
项目总结/摘要
联系PD/PI:Urban,Randall J.
叙事
UTMB的CTSA中心将与当地,区域和国家合作伙伴合作,支持转化研究,
加速健康发现。我们将培养多元化的劳动力,建立多学科团队
在整个生命周期内进行高效、高质量的临床研究,包括研究不足的人群。
我们将整合我们的研究和医疗保健活动,并将生成,应用和共享数据,
各机构的做法。
第431页
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Randall J Urban其他文献
Anterior hypopituitarism following traumatic brain injury
脑外伤后垂体前叶功能低下
- DOI:
- 发表时间:
2005 - 期刊:
- 影响因子:1.9
- 作者:
Randall J Urban;P. Harris;B. Masel - 通讯作者:
B. Masel
Randall J Urban的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Randall J Urban', 18)}}的其他基金
UTMB Clinical and Translational Science Award
UTMB 临床和转化科学奖
- 批准号:
10376310 - 财政年份:2015
- 资助金额:
$ 277.46万 - 项目类别:
UTMB Clinical and Translational Science Award
UTMB 临床和转化科学奖
- 批准号:
10568556 - 财政年份:2015
- 资助金额:
$ 277.46万 - 项目类别:
UTMB Clinical and Translational Science Award
UTMB 临床和转化科学奖
- 批准号:
10259247 - 财政年份:2015
- 资助金额:
$ 277.46万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 277.46万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 277.46万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 277.46万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 277.46万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 277.46万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 277.46万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 277.46万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 277.46万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 277.46万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 277.46万 - 项目类别:
Research Grant














{{item.name}}会员




